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Neutrophils are the most numerous immune cells. Their importance as the first line of 
defense against bacterial and fungal pathogens is well described. In contrast, the role of 
neutrophils in controlling viral infections is less clear. Bacterial and fungal pathogens can 
stimulate neutrophils extracellular traps (NETs) in a process called NETosis. Although 
NETosis has previously been described as a special form of programmed cell death, 
there are forms of NET production that do not end with the demise of neutrophils. 
As an end result of NETosis, genomic DNA complexed with microbicidal proteins is 
expelled from neutrophils. These structures can kill pathogens or at least prevent their 
local spread within host tissue. On the other hand, disproportionate NET formation 
can cause local or systemic damage. Only recently, it was recognized that viruses can 
also induce NETosis. In this review, we discuss the mechanisms by which NETs are 
produced in the context of viral infection and how this may contribute to both antiviral 
immunity and immunopathology. Finally, we shed light on viral immune evasion mech-
anisms targeting NETs.
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inTRODUCTiOn
As the first line of defense against invading pathogens, neutrophils have a broad arsenal of antimi-
crobial functions (1). For example, activated neutrophils release granules containing antimicrobial 
molecules and produce reactive oxygen species (ROS) by oxidative burst. An alternative antimicro-
bial function of neutrophils is based on a special type of programmed cell death called NETosis that 
is distinct from apoptosis and necrosis (2, 3). During NETosis, the nuclei of neutrophils lose their 
characteristic shape, and chromatin decondensation takes place (4). Subsequently, the membranes of 
the nucleus and the granules disintegrate, allowing the mixing of their content. Finally, neutrophils 
release neutrophil extracellular traps (NETs). NETs are net-like structures that are composed of 
chromatin and endowed with granule proteins. They bind to, entrap, and often kill certain pathogens. 
NETs are released particularly in response to large microbial structures that cannot be easily phago-
cytosed such as Candida albicans hyphae and Mycobacterium bovis aggregates (5).
Classical NETosis requires the generation of ROS by NADPH oxidase. However, mitochondrial 
ROS production in the absence of a functional NADPH oxidase is sufficient to trigger NETosis 
(6). Moreover, a very rapid and ROS-independent form of NETosis is triggered by Staphylococcus 
aureus (7). Thus, depending on the stimulus NADPH is not always required for NET formation (8). 
Similar to necrosis and apoptosis, there are different forms of NETosis (9, 10). For example, it has 
been observed that NET formation can occur without concomitant neutrophil death (7, 11–14). The 
physiological and pathological meanings of these different NETosis forms still have to be elucidated.
FiGURe 1 | induction, antiviral effect, and viral evasion of neTs. (1) 
Formation of NETs is induced directly by virions (red) through PRRs (blue) 
expressed by neutrophils on the surface (TLR4, β2 integrins) or in endosomes 
(TLR7, 8) or indirectly by proinflammatory mediators (e.g., IL-8), which are 
released from virus-infected cells (orange). In addition, viral activation of the 
platelet/neutrophil axis can trigger NETosis (green). As a consequence, 
granules fuse with the nucleus, which subsequently loses its characteristic 
lobulated shape and ruptures. Finally, neutrophils rupture releasing sticky 
strings of NETs. (2) NETs have antiviral effects by immobilizing or inactivating 
free virions, thereby preventing viral spread. NETs also potentiate the release 
of type I interferon by pDC (not shown), thus increasing the resistance of local 
cells to further infection. (3) Digestion of the DNA backbone by DNases 
releases trapped virions. These virions, if not already inactivated, opsonized, 
or degraded, can attempt to infect further cells. Moreover, viruses can 
interfere with NETosis by inducing cellular IL-10 or by expressing viral IL-10 
homologs (not shown).
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Only recently, it was recognized that NETs are also generated 
during viral infection (15–17). Evidence is accumulating that 
neutrophils play a role in antiviral immune responses (18). These 
virus-induced NETs can both control the virus and damage the 
host (19). In this review, we focus our attention on the physiologi-
cal and pathological relevance of virus-induced NETosis.
viRAL neT inDUCTiOn
Many viruses stimulate neutrophils in vitro directly to produce 
NETs at low levels (20). Some of these viruses can be detected 
inside neutrophils, but there is no direct evidence that they 
establish productive infection in this cell type (20–23). This 
suggests that pattern recognition receptors (PRRs) expressed on 
the surface or in endosomes of neutrophils play an essential role 
in NETosis (Figure  1). For example, neutrophils sense HIV-1 
by endosomal PRRs that detect viral nucleic acids, i.e., toll-like 
receptor (TLR) 7 and TLR8, and subsequently undergo NETosis 
(17). The fusion protein of respiratory syncytial virus (RSV) 
induces NETosis through TLR4 (24). NET formation induced by 
hantaviruses is mediated by signaling through β2 integrins (20). 
Influenza virus A can also stimulate neutrophils directly to release 
NETs; however, the molecules involved have not been defined 
(25). Surprisingly, influenza A virus-induced NETs do not protect 
against secondary bacterial infection (26). Thus, virus-induced 
NETs differ structurally and functionally from those generated 
during bacterial infection. In line with this view, the protein con-
tent of NETs depends on the type of NET-inducing stimulus (27).
In the context of viral infection, neutrophils can switch on 
antiviral effector programs other than NETosis, such as release of 
antiviral agents or phagocytosis, and can even become apoptotic 
(18). At the moment, it is unclear how neutrophils decide between 
these different responses. Possibly, not a single PRR but rather as-
yet undefined combinations of neutrophilic PRRs determine the 
antiviral mode of action of neutrophils. Moreover, only a proportion 
of cells undergo NETosis, suggesting that only a special neutrophil 
subtype or maturation stage is susceptible to NETosis induction (4).
Viruses also induce NETosis indirectly without engaging 
PRRs expressed by neutrophils (Figure  1). The inflammatory 
milieu created by virus-infected endothelial and epithelial cells 
contains cytokines and chemokines such as interleukin-8 (IL-8) 
that trigger NETosis (3, 28, 29). In addition, type I interferon 
(IFN) is produced in large amounts during viral infections and 
primes neutrophils for NET formation (30). There is also evi-
dence that platelets play an important role in antiviral defense 
(31). Platelet activation is frequently observed during viral infec-
tions. For example, single-stranded RNA viruses from the family 
Picornaviridae activate platelets through TLR7. This is important 
for reducing viral titers and increasing the survival of the host (32, 
33). Activated platelets form aggregates with neutrophils and in 
this process stimulate NETosis (34) (Figure 1). On the molecular 
level, this NET-inducing aggregation has been attributed to sur-
face molecules: CD41 on activated platelets interacts with CD11b, 
a β2 integrin, on neutrophils. Other infection models have also 
shown that platelet–neutrophil interactions through β2 integrins 
induce NET formation (11, 35, 36). Massive activation of the 
platelet/neutrophil axis and subsequent NET-based clearance 
mechanisms may represent an emergency strategy of the host 
in the face of systemically multiplying viruses. This reaction is 
followed by a drop in platelet counts, which is observed in many 
viral infections, e.g., viral hemorrhagic fever (VHF) caused by 
hantaviruses (37, 38). In fact, the degree of platelet loss correlates 
with the severity of virus-induced disease and determines the 
clinical outcome (39–41).
AnTiviRAL ACTiviTY OF neTs
Although virus induction of NET formation is now well estab-
lished, it is less clear how NETs contribute to antiviral immunity. 
In a mouse model of poxvirus infection, induction of NETs 
with LPS prior to infection strongly reduced the number of 
virus-infected liver cells and this protective effect was reversed 
by DNase treatment (34). There are direct mechanisms by which 
NETs develop antiviral activity (Figure 1). First of all, the web-like 
chromatin backbone of NETs can bind to and immobilize viral 
particles, in part by electrostatic attraction, thereby mechani-
cally preventing virus spreading (17). Histones are enriched 
in positively charged amino acids and can attach to negatively 
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charged viral envelope. For example, the core histones H3 and 
H4 induce aggregation of seasonal influenza A particles and may 
inactivate HIV-1 (17, 42). Intriguingly, extracellular histones also 
reduce HIV-1 transcription (43). Finally, histone H1 binds to 
noroviruses, the most common cause of viral gastroenteritis and 
prevents their attachment to intestinal cells (44). Second, attached 
to the chromatin backbone of NETs are antimicrobial molecules 
such as myeloperoxidase (MPO), cathelicidins, and α-defensin. 
They have a proven antiviral activity against both enveloped and 
non-enveloped viruses and can inactivate viral particles (45).
NETs components also indirectly contribute to antiviral 
immunity by stimulating antiviral effector mechanisms executed 
by other immune cells. For example, histones and high mobility 
group box-1 (HMGB1) proteins act as danger-associated molecu-
lar patterns (DAMPs) that trigger release of proinflammatory 
cytokines and chemokines by other immune cells (46). This 
process is self-limiting as under high neutrophil densities NETs 
build aggregates that in turn degrade cytokines and chemokines 
(47). NETs also activate plasmacytoid dendritic cells (pDCs) 
through TLRs (48–50). pDCs have a key function in antiviral 
immunity by releasing high amounts of type I IFN (51). In fact, 
NETs can be enriched in oxidized mitochondrial DNA which 
is very efficient in inducing a type I IFN response (52). Finally, 
NETs could increase antiviral adaptive immunity by reducing the 
activation threshold of T lymphocytes (53).
viRAL neT evASiOn
Viruses are known for their extraordinary capacity to evade 
immune control mechanisms. There are also viral mechanisms 
that counteract NET formation (Figure 1). For example, HIV-1 
envelope glycoprotein stimulates DCs to produce cellular IL-10 
through DC-SIGN (17). IL-10 is an immunosuppressive cytokine 
that also inhibits TLR-induced ROS production (54). It is quite 
often produced in the context of viral infections suggesting that 
more viruses exploit IL-10 as a means of NET evasion (55, 56). 
In the genome of several large DNA viruses IL-10, homologs 
have been found including ubiquitous human pathogens such 
as human cytomegalovirus (HCMV) and Epstein–Barr virus 
(EBV) (57, 58). As these virus-encoded IL-10 molecules shape 
the function and cell death of immune cells, they may also 
modulate NETosis similar to cellular IL-10 (59, 60). Dengue 
virus (DENV) serotype-2 can arrest NET formation at a ROS-
independent late stage by interfering with glucose uptake (61, 62). 
Finally, latency-associated nuclear antigen 1 encoded by Kaposi’s 
sarcoma-associated herpesvirus (KSHV) impairs expression of 
NET-stimulating cellular IL-8 (63).
Some bacteria, such as streptococci, express DNase to degrade 
NETs (64–66). Herpesviruses also encode proteins that have 
DNAse activity. These viral molecules process and package the 
replicated viral genome into the capsid (67). If released from 
virus-infected cells, they could degrade NETs, thereby remobiliz-
ing NET-entrapped virions.
Taken together, virus-induced NETs help to control viral dis-
semination by several direct and indirect mechanisms, whereas at 
the same time viral evasion mechanisms target NET formation to 
minimize the antiviral NET effect and immunopathology.
ROLe OF neTs in viRAL PATHOGeneSiS
As for all effective immune responses against pathogens, NETosis 
may also result in immunopathology. Unbalanced NET forma-
tion is associated with pathological conditions such as respiratory 
distress, autoimmune disease, and thrombosis (68). NETs are 
directly cytotoxic to epithelial and endothelial cells (69, 70) as 
well as hepatocytes (71). They contain several components such 
as histones that are antimicrobial but at the same time can cause 
tissue damage and other pathological abnormalities including 
thrombosis (72). Moreover, NETs can occlude secretory ducts 
or small airways, thereby driving inflammation (73, 74). Other 
components of NETs such as HMGB1 may also play a detrimental 
role in virus-associated disease (75).
There is evidence supporting the concept that local NET 
deposits contribute to viral immunopathology. NETs have been 
detected in bronchoalveolar lavage fluid from children with severe 
RSV infection of the lower respiratory tract (76). Dense plugs 
occluding the small airways in RSV-infected calves contain NETs 
(76). Moreover, in a mouse model of influenza pneumonia, NET 
formation was observed in areas of alveolar-capillary damage in 
the lung (16). On the other hand, mice deficient in peptidylargi-
nine deiminase 4 (PAD4) were as efficient in controlling influenza 
virus and showed similar survival as wild-type mice (77). This 
result suggests that NETs do not play an important role in indi-
vidual antiviral immunity and virus-induced pathology because 
PAD4 deiminates histone H3 and H4 and is required for NET 
formation. The different outcomes of these studies may be due 
to different virus and mouse strains used. In line with this view, 
neutrophils from different mouse strains undergo NETosis with 
different efficiency (78). Furthermore, the influence of NETs on 
viral dissemination was not addressed in these studies. If virus-
induced NET deposits represent an important pathogenic factor 
treatments that alleviate NET-induced pathological manifesta-
tions such as DNase should ease symptoms of virus-associated 
disease (79). Clinical or radiological improvement after DNase 
treatment of infants with virus-associated bronchiolitis was 
observed in some clinical trials (80, 81) but not in others (82). 
Thus, further studies have to elucidate the precise pathogenic 
role of virus-induced NET deposits in the lung and explore the 
efficiency of anti-NET treatment.
NETs start to circulate in detectable amounts in the serum 
if the NET degradation and clearance machinery of the host is 
overwhelmed. This systemic NET overflow has severe direct and 
indirect adverse effects. First, NETs can damage directly endothe-
lial cells lining the interior face of the blood vessels cells (69, 70). 
Second, NET overflow drives autodestructive processes as com-
ponents of NETs act as neo self-antigens and induce autoantibod-
ies. In fact, a number of molecules that have been identified as 
important targets in autoimmune diseases (e.g., dsDNA, histones, 
MPO, vimentin, and enolase) are actually NET components. 
Accordingly, NETs have been connected to systemic pathology 
associated with disease entities such as small vessel-vasculitis, 
systemic lupus erythematosus (SLE), disseminated intravascular 
coagulation, rheumatoid arthritis, and preeclampsia (83, 84).
Systemic NET overflow may result from clearance defi-
ciency or increased NET production. For example, sera from a 
FiGURe 2 | Systemic pathology driven by virus-induced neT 
formation. Virus-induced NETs may start to circulate and become systemic 
under certain circumstances. First, systemic infection with viruses that have a 
strong NET-stimulatory capacity, such as hantaviruses, may overwhelm intact 
NET-degrading function of DNAses (20). Second, persistent viruses with low 
NET-inducing capacity, such as herpesviruses, may produce systemic NET 
excess if DNAse activity is compromised. As a result of NET overflow, 
self-reactive memory B cells are stimulated to release autoantibodies after 
binding and internalizing NET components through their B cell receptor (91). 
NETs are enriched in oxidized mitochondrial DNA inducing a strong 
inflammatory response (52). NETs stimulate pDCs to release type I IFN that 
adds momentum to the vicious cycle by further activating and expanding 
autoreactive B cells (48–50). Immune complexes are formed which not only 
cause systemic pathology as observed in several disease entities such as 
SLE but also promote the autoimmune process by driving a positive 
feedback loop.
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subpopulation of SLE patients show decreased DNase I activity 
and NET degradation (85, 86). Another enzyme that could 
prevent systemic NET overflow is DNASE1L3. It is released by 
DCs and macrophages and digests microparticle-associated 
chromatin, thereby preventing SLE (87). In those individuals 
who are deficient in NET-degrading enzymes even viruses with 
a relatively weak NETs-stimulatory capacity could drive NET-
associated systemic pathology (Figure 2). NET formation repre-
sents a plausible link between viruses and systemic autoimmune 
disease. Supporting this idea, viral infections are associated with 
transient autoantibody production and are known to mimic SLE, 
induce SLE onset, or trigger lupus flares (88–90).
Transient systemic NET overflow due to increased NET for-
mation without noticeable deficiency in DNase activity can occur 
during infection with hantaviruses (20) (Figure 2). Neutrophils 
play an antiviral role during VHF caused by hantaviruses (92–94). 
These zoonotic pathogens belong to the family Bunyaviridae and 
infect humans after transmission via inhalation of aerosolized 
urine, saliva, and feces from chronically infected rodents, their 
natural hosts. In humans, they can induce severe pulmonary and 
renal dysfunction as well as intravascular coagulation and hemor-
rhagic shock (95). Hantaviruses replicate in endothelial cells, their 
main target cells, without causing programed cell death in vitro. 
This suggests that immunopathological mechanisms such as those 
driven by NETs contribute to Hantavirus-associated pathogenesis 
(94, 96). In hantavirus-infected patients, high levels of circulat-
ing NETs are detected (20). In accordance, increased amounts of 
cell-free DNA (97) and histones (98) are found in the circulation 
of hantavirus-infected individuals. The cytotoxic effects of NETs 
may significantly contribute to hantavirus-associated pathology. 
In line with this view, histones have been shown to increase 
thrombin generation and intravascular coagulation (99, 100). 
They also upregulate the permeability of the endothelial barrier 
(101). Finally, NETs can induce the formation of autoantibodies 
that may contribute to the systemic pathology observed during 
hantavirus-associated disease (20).
Another form of VHF is caused by DENV. DENV is transmit-
ted between humans by Aedes mosquitoes and poses a threat to 
roughly two billion people (102). There is no evidence as yet for 
a strong direct NET-stimulatory effect of DENV particles in vitro 
(61). Nevertheless, in vivo DENV-infected cells could stimulate 
NETosis indirectly by secreting the viral non-structural protein 1 
(NS1). NS1 activates uninfected cells including endothelial cells 
via TLR4 (103, 104). Subsequently, activated endothelial cells 
could drive neutrophils into NETosis (69, 79). Moreover, NS1 
could activate platelets via TLR4 which in turn stimulate neu-
trophils to undergo NETosis (105). Finally, IL-8 is produced by 
human endothelial cells in response to DENV (29) and is known 
to drive NETosis (3). In accordance, high levels of IL-8 and 
elastase, a key component of NETs, are found in DENV patients 
and correlate with disease severity (106).
These pathological effects explain why NET formation as part 
of an antiviral defense strategy is a double-edged sword. The host 
may benefit from NETs deposited precisely in the area of infec-
tion, thereby immobilizing or even neutralizing virus and killing 
virus-infected cells. This benefit may turn into disaster if NET 
formation is too widespread creating NET deposits in healthy 
tissue. As a consequence, too many uninfected host cells in the 
neighborhood of the infected areal may come under “friendly 
fire” resulting in considerable collateral tissue damage. Local 
NET-associated pathology may become systemic, if the NET 
degradation machinery (DNase activity) is impaired, or if the 
viral NET-stimulatory capacity is too strong. Such an unbalanced 
NET formation results in NET overflow. Under this condition, 
autoimmune phenomena are triggered that could result in sys-
temic pathology (Figure 2).
COnCLUDinG ReMARKS
It is now evident that most pathogens, including viruses, can 
stimulate neutrophils to undergo NETosis. Although much 
smaller than bacteria, fungi, or parasites, viral particles do not 
seem to slip through NETs but rather become immobilized. 
Whether these viral particles are inactivated as well is a moot 
point, as long as they are ensnared by NETs, they represent no 
threat. However, an increasing number of studies indicate that 
a disproportionate virus-induced NET release can contribute 
to damage, locally as well as systemically. It will be important 
to explore the mechanisms that control NET formation in the 
context of viral infections. On the basis of this knowledge, it could 
be possible to prevent NET-assisted control of viruses becoming 
a Pyrrhic victory.
5Schönrich and Raftery Virus-Induced NETosis
Frontiers in Immunology | www.frontiersin.org September 2016 | Volume 7 | Article 366
AUTHOR COnTRiBUTiOnS
Both authors contributed to the conception, writing, and editing 
of this review.
FUnDinG
This work was supported by Deutsche Forschungsgemeinschaft 
(Support code SCHO/9-1).
ReFeRenCeS
1. Bardoel BW, Kenny EF, Sollberger G, Zychlinsky A. The balancing act of neu-
trophils. Cell Host Microbe (2014) 15:526–36. doi:10.1016/j.chom.2014.04.011 
2. Takei H, Araki A, Watanabe H, Ichinose A, Sendo F. Rapid killing of human 
neutrophils by the potent activator phorbol 12-myristate 13-acetate (PMA) 
accompanied by changes different from typical apoptosis or necrosis. 
J Leukoc Biol (1996) 59:229–40. 
3. Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, 
et al. Neutrophil extracellular traps kill bacteria. Science (2004) 303:1532–5. 
doi:10.1126/science.1092385 
4. Fuchs TA, Abed U, Goosmann C, Hurwitz R, Schulze I, Wahn V, et al. Novel 
cell death program leads to neutrophil extracellular traps. J Cell Biol (2007) 
176:231–41. doi:10.1083/jcb.200606027 
5. Branzk N, Lubojemska A, Hardison SE, Wang Q, Gutierrez MG, Brown GD, 
et  al. Neutrophils sense microbe size and selectively release neutrophil 
extracellular traps in response to large pathogens. Nat Immunol (2014) 
15:1017–25. doi:10.1038/ni.2987 
6. Douda DN, Khan MA, Grasemann H, Palaniyar N. SK3 channel and mito-
chondrial ROS mediate NADPH oxidase-independent NETosis induced by 
calcium influx. Proc Natl Acad Sci U S A (2015) 112:2817–22. doi:10.1073/
pnas.1414055112 
7. Pilsczek FH, Salina D, Poon KK, Fahey C, Yipp BG, Sibley CD, et  al.  
A novel mechanism of rapid nuclear neutrophil extracellular trap formation 
in response to Staphylococcus aureus. J Immunol (2010) 185:7413–25. 
doi:10.4049/jimmunol.1000675 
8. Parker H, Dragunow M, Hampton MB, Kettle AJ, Winterbourn CC. 
Requirements for NADPH oxidase and myeloperoxidase in neutrophil 
extracellular trap formation differ depending on the stimulus. J Leukoc Biol 
(2012) 92:841–9. doi:10.1189/jlb.1211601 
9. Yipp BG, Kubes P. NETosis: how vital is it? Blood (2013) 122:2784–94. 
doi:10.1182/blood-2013-04-457671 
10. Desai J, Mulay SR, Nakazawa D, Anders HJ. Matters of life and death. How 
neutrophils die or survive along NET release and is “NETosis” = necroptosis? 
Cell Mol Life Sci (2016) 73:2211–9. doi:10.1007/s00018-016-2195-0 
11. Clark SR, Ma AC, Tavener SA, McDonald B, Goodarzi Z, Kelly MM, et al. 
Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in 
septic blood. Nat Med (2007) 13:463–9. doi:10.1038/nm1565 
12. Yousefi S, Mihalache C, Kozlowski E, Schmid I, Simon HU. Viable neutro-
phils release mitochondrial DNA to form neutrophil extracellular traps. Cell 
Death Differ (2009) 16:1438–44. doi:10.1038/cdd.2009.96 
13. Yipp BG, Petri B, Salina D, Jenne CN, Scott BN, Zbytnuik LD, et al. Infection-
induced NETosis is a dynamic process involving neutrophil multitasking 
in vivo. Nat Med (2012) 18:1386–93. doi:10.1038/nm.2847 
14. Byrd AS, O’Brien XM, Johnson CM, Lavigne LM, Reichner JS. An extracellu-
lar matrix-based mechanism of rapid neutrophil extracellular trap formation 
in response to Candida albicans. J Immunol (2013) 190:4136–48. doi:10.4049/
jimmunol.1202671 
15. Wardini AB, Guimaraes-Costa AB, Nascimento MT, Nadaes NR, Danelli MG, 
Mazur C, et  al. Characterization of neutrophil extracellular traps in cats 
naturally infected with feline leukemia virus. J Gen Virol (2010) 91:259–64. 
doi:10.1099/vir.0.014613-0 
16. Narasaraju T, Yang E, Samy RP, Ng HH, Poh WP, Liew AA, et al. Excessive 
neutrophils and neutrophil extracellular traps contribute to acute lung injury 
of influenza pneumonitis. Am J Pathol (2011) 179:199–210. doi:10.1016/ 
j.ajpath.2011.03.013 
17. Saitoh T, Komano J, Saitoh Y, Misawa T, Takahama M, Kozaki T, et  al. 
Neutrophil extracellular traps mediate a host defense response to human 
immunodeficiency virus-1. Cell Host Microbe (2012) 12:109–16. doi:10.1016/ 
j.chom.2012.05.015 
18. Galani IE, Andreakos E. Neutrophils in viral infections: current concepts and 
caveats. J Leukoc Biol (2015) 98:557–64. doi:10.1189/jlb.4VMR1114-555R 
19. Jenne CN, Kubes P. Virus-induced NETs – critical component of host defense 
or pathogenic mediator? PLoS Pathog (2015) 11:e1004546. doi:10.1371/
journal.ppat.1004546 
20. Raftery MJ, Lalwani P, Krautkrämer E, Peters T, Scharffetter-Kochanek 
K, Kruger R, et  al. beta2 integrin mediates hantavirus-induced release of 
neutrophil extracellular traps. J Exp Med (2014) 211:1485–97. doi:10.1084/
jem.20131092 
21. Orenstein JM. In vivo cytolysis and fusion of human immunodeficiency 
virus type 1-infected lymphocytes in lymphoid tissue. J Infect Dis (2000) 
182:338–42. doi:10.1086/315640 
22. Gerna G, Baldanti F, Revello MG. Pathogenesis of human cytomegalovirus 
infection and cellular targets. Hum Immunol (2004) 65:381–6. doi:10.1016/ 
j.humimm.2004.02.009 
23. Halfhide CP, Flanagan BF, Brearey SP, Hunt JA, Fonceca AM, McNamara PS, 
et  al. Respiratory syncytial virus binds and undergoes transcription in 
neutrophils from the blood and airways of infants with severe bronchiolitis. 
J Infect Dis (2011) 204:451–8. doi:10.1093/infdis/jir280 
24. Funchal GA, Jaeger N, Czepielewski RS, Machado MS, Muraro SP, Stein RT, 
et al. Respiratory syncytial virus fusion protein promotes TLR-4-dependent 
neutrophil extracellular trap formation by human neutrophils. PLoS One 
(2015) 10:e0124082. doi:10.1371/journal.pone.0124082 
25. Tripathi S, Verma A, Kim EJ, White MR, Hartshorn KL. LL-37 modulates 
human neutrophil responses to influenza A virus. J Leukoc Biol (2014) 
96:931–8. doi:10.1189/jlb.4A1113-604RR 
26. Narayana Moorthy A, Narasaraju T, Rai P, Perumalsamy R, Tan KB, Wang S, 
et al. In vivo and in vitro studies on the roles of neutrophil extracellular traps 
during secondary pneumococcal pneumonia after primary pulmonary influ-
enza infection. Front Immunol (2013) 4:56. doi:10.3389/fimmu.2013.00056 
27. Khandpur R, Carmona-Rivera C, Vivekanandan-Giri A, Gizinski A, 
Yalavarthi S, Knight JS, et al. NETs are a source of citrullinated autoantigens 
and stimulate inflammatory responses in rheumatoid arthritis. Sci Transl 
Med (2013) 5:178ra140. doi:10.1126/scitranslmed.3005580 
28. Subauste MC, Jacoby DB, Richards SM, Proud D. Infection of a human 
respiratory epithelial cell line with rhinovirus. Induction of cytokine release 
and modulation of susceptibility to infection by cytokine exposure. J Clin 
Invest (1995) 96:549–57. doi:10.1172/JCI118067 
29. Huang YH, Lei HY, Liu HS, Lin YS, Liu CC, Yeh TM. Dengue virus infects 
human endothelial cells and induces IL-6 and IL-8 production. Am J Trop 
Med Hyg (2000) 63:71–5. 
30. Martinelli S, Urosevic M, Daryadel A, Oberholzer PA, Baumann C, Fey MF, 
et al. Induction of genes mediating interferon-dependent extracellular trap 
formation during neutrophil differentiation. J Biol Chem (2004) 279:44123–
32. doi:10.1074/jbc.M405883200 
31. Assinger A. Platelets and infection – an emerging role of platelets in 
viral infection. Front Immunol (2014) 5:649. doi:10.3389/fimmu.2014. 
00649 
32. Koupenova M, Vitseva O, Mackay CR, Beaulieu LM, Benjamin EJ, Mick E, 
et  al. Platelet-TLR7 mediates host survival and platelet count during viral 
infection in the absence of platelet-dependent thrombosis. Blood (2014) 
124:791–802. doi:10.1182/blood-2013-11-536003 
33. Negrotto S, Jaquenod De Giusti C, Rivadeneyra L, Ure AE, Mena HA, 
Schattner M, et al. Platelets interact with coxsackieviruses B and have a criti-
cal role in the pathogenesis of virus-induced myocarditis. J Thromb Haemost 
(2015) 13:271–82. doi:10.1111/jth.12782 
34. Jenne CN, Wong CH, Zemp FJ, McDonald B, Rahman MM, Forsyth PA, et al. 
Neutrophils recruited to sites of infection protect from virus challenge by 
releasing neutrophil extracellular traps. Cell Host Microbe (2013) 13:169–80. 
doi:10.1016/j.chom.2013.01.005 
35. Caudrillier A, Kessenbrock K, Gilliss BM, Nguyen JX, Marques MB, 
Monestier M, et al. Platelets induce neutrophil extracellular traps in transfu-
sion-related acute lung injury. J Clin Invest (2012) 122:2661–71. doi:10.1172/
JCI61303 
6Schönrich and Raftery Virus-Induced NETosis
Frontiers in Immunology | www.frontiersin.org September 2016 | Volume 7 | Article 366
36. McDonald B, Urrutia R, Yipp BG, Jenne CN, Kubes P. Intravascular 
 neutrophil extracellular traps capture bacteria from the bloodstream during 
sepsis. Cell Host Microbe (2012) 12:324–33. doi:10.1016/j.chom.2012.06.011 
37. Zapata JC, Cox D, Salvato MS. The role of platelets in the pathogenesis of 
viral hemorrhagic fevers. PLoS Negl Trop Dis (2014) 8:e2858. doi:10.1371/
journal.pntd.0002858 
38. Connolly-Andersen AM, Sundberg E, Ahlm C, Hultdin J, Baudin M, Larsson J, 
et al. Increased thrombopoiesis and platelet activation in hantavirus-infected 
patients. J Infect Dis (2015) 212:1061–9. doi:10.1093/infdis/jiv161 
39. Rasche FM, Uhel B, Kruger DH, Karges W, Czock D, Hampl W, et  al. 
Thrombocytopenia and acute renal failure in Puumala hantavirus infections. 
Emerg Infect Dis (2004) 10:1420–5. doi:10.3201/eid1008.031069 
40. Krautkramer E, Zeier M, Plyusnin A. Hantavirus infection: an emerging 
infectious disease causing acute renal failure. Kidney Int (2013) 83:23–7. 
doi:10.1038/ki.2012.360 
41. Latus J, Schwab M, Tacconelli E, Pieper FM, Wegener D, Rettenmaier B, 
et al. Acute kidney injury and tools for risk-stratification in 456 patients with 
hantavirus-induced nephropathia epidemica. Nephrol Dial Transplant (2015) 
30:245–51. doi:10.1093/ndt/gfu319 
42. Hoeksema M, Tripathi S, White M, Qi L, Taubenberger J, Van Eijk M, et al. 
Arginine-rich histones have strong antiviral activity for influenza A viruses. 
Innate Immun (2015) 21:736–45. doi:10.1177/1753425915593794 
43. Kozlowski HN, Lai ET, Havugimana PC, White C, Emili A, Sakac D, et al. 
Extracellular histones identified in crocodile blood inhibit in  vitro HIV-1 
infection. AIDS (2016) 30:2043–52. doi:10.1097/QAD.0000000000001159 
44. Tamura M, Natori K, Kobayashi M, Miyamura T, Takeda N. Inhibition of 
attachment of virions of Norwalk virus to mammalian cells by soluble histone 
molecules. Arch Virol (2003) 148:1659–70. doi:10.1007/s00705-003-0143-4 
45. Gwyer Findlay E, Currie SM, Davidson DJ. Cationic host defence peptides: 
potential as antiviral therapeutics. BioDrugs (2013) 27:479–93. doi:10.1007/
s40259-013-0039-0 
46. Xu J, Zhang X, Monestier M, Esmon NL, Esmon CT. Extracellular histones 
are mediators of death through TLR2 and TLR4 in mouse fatal liver injury. 
J Immunol (2011) 187:2626–31. doi:10.4049/jimmunol.1003930 
47. Schauer C, Janko C, Munoz LE, Zhao Y, Kienhofer D, Frey B, et al. Aggregated 
neutrophil extracellular traps limit inflammation by degrading cytokines and 
chemokines. Nat Med (2014) 20:511–7. doi:10.1038/nm.3547 
48. Garcia-Romo GS, Caielli S, Vega B, Connolly J, Allantaz F, Xu Z, et  al. 
Netting neutrophils are major inducers of type I IFN production in pediatric 
systemic lupus erythematosus. Sci Transl Med (2011) 3:73ra20. doi:10.1126/
scitranslmed.3001201 
49. Lande R, Ganguly D, Facchinetti V, Frasca L, Conrad C, Gregorio J, 
et  al. Neutrophils activate plasmacytoid dendritic cells by releasing 
 self-DNA-peptide complexes in systemic lupus erythematosus. Sci Transl 
Med (2011) 3:73ra19. doi:10.1126/scitranslmed.3001180 
50. Villanueva E, Yalavarthi S, Berthier CC, Hodgin JB, Khandpur R, Lin AM, 
et al. Netting neutrophils induce endothelial damage, infiltrate tissues, and 
expose immunostimulatory molecules in systemic lupus erythematosus. 
J Immunol (2011) 187:538–52. doi:10.4049/jimmunol.1100450 
51. Swiecki M, Colonna M. The multifaceted biology of plasmacytoid dendritic 
cells. Nat Rev Immunol (2015) 15:471–85. doi:10.1038/nri3865 
52. Lood C, Blanco LP, Purmalek MM, Carmona-Rivera C, De Ravin SS, 
Smith CK, et al. Neutrophil extracellular traps enriched in oxidized mito-
chondrial DNA are interferogenic and contribute to lupus-like disease. Nat 
Med (2016) 22:146–53. doi:10.1038/nm.4027 
53. Tillack K, Breiden P, Martin R, Sospedra M. T lymphocyte priming by 
neutrophil extracellular traps links innate and adaptive immune responses. 
J Immunol (2012) 188:3150–9. doi:10.4049/jimmunol.1103414 
54. Chang J, Kunkel SL, Chang CH. Negative regulation of MyD88-dependent 
signaling by IL-10 in dendritic cells. Proc Natl Acad Sci U S A (2009) 
106:18327–32. doi:10.1073/pnas.0905815106 
55. Ng CT, Oldstone MB. IL-10: achieving balance during persistent 
viral infection. Curr Top Microbiol Immunol (2014) 380:129–44. 
doi:10.1007/978-3-662-43492-5_6 
56. Shen P, Fillatreau S. Suppressive functions of B cells in infectious diseases. Int 
Immunol (2015) 27:513–9. doi:10.1093/intimm/dxv037 
57. Hsu DH, De Waal Malefyt R, Fiorentino DF, Dang MN, Vieira P, De Vries J, 
et  al. Expression of interleukin-10 activity by Epstein-Barr virus protein 
BCRF1. Science (1990) 250:830–2. doi:10.1126/science.2173142 
58. Kotenko SV, Saccani S, Izotova LS, Mirochnitchenko OV, Pestka S. Human 
cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc 
Natl Acad Sci U S A (2000) 97:1695–700. doi:10.1073/pnas.97.4.1695 
59. Raftery M, Muller A, Schonrich G. Herpesvirus homologues of cellular genes. 
Virus Genes (2000) 21:65–75. doi:10.1023/A:1008184330127 
60. Raftery MJ, Wieland D, Gronewald S, Kraus AA, Giese T, Schonrich G. 
Shaping phenotype, function, and survival of dendritic cells by cytomeg-
alovirus-encoded IL-10. J Immunol (2004) 173:3383–91. doi:10.4049/
jimmunol.173.5.3383 
61. Moreno-Altamirano MM, Rodriguez-Espinosa O, Rojas-Espinosa O, 
Pliego-Rivero B, Sanchez-Garcia FJ. Dengue virus serotype-2 interferes with 
the formation of neutrophil extracellular traps. Intervirology (2015) 58:250–9. 
doi:10.1159/000440723 
62. Rodriguez-Espinosa O, Rojas-Espinosa O, Moreno-Altamirano MM, 
Lopez-Villegas EO, Sanchez-Garcia FJ. Metabolic requirements for 
neutrophil extracellular traps formation. Immunology (2015) 145:213–24. 
doi:10.1111/imm.12437 
63. Li X, Liang D, Lin X, Robertson ES, Lan K. Kaposi’s sarcoma-associated her-
pesvirus-encoded latency-associated nuclear antigen reduces  interleukin-8 
expression in endothelial cells and impairs neutrophil chemotaxis by 
degrading nuclear p65. J Virol (2011) 85:8606–15. doi:10.1128/JVI. 
00733-11 
64. Sumby P, Barbian KD, Gardner DJ, Whitney AR, Welty DM, Long RD, 
et al. Extracellular deoxyribonuclease made by group A Streptococcus assists 
pathogenesis by enhancing evasion of the innate immune response. Proc Natl 
Acad Sci U S A (2005) 102:1679–84. doi:10.1073/pnas.0406641102 
65. Beiter K, Wartha F, Albiger B, Normark S, Zychlinsky A, Henriques-
Normark B. An endonuclease allows Streptococcus pneumoniae to escape 
from neutrophil extracellular traps. Curr Biol (2006) 16:401–7. doi:10.1016/ 
j.cub.2006.01.056 
66. Walker MJ, Hollands A, Sanderson-Smith ML, Cole JN, Kirk JK, 
Henningham A, et al. DNase Sda1 provides selection pressure for a switch 
to invasive group A streptococcal infection. Nat Med (2007) 13:981–5. 
doi:10.1038/nm1612 
67. Martinez R, Sarisky RT, Weber PC, Weller SK. Herpes simplex virus type 1 
alkaline nuclease is required for efficient processing of viral DNA replication 
intermediates. J Virol (1996) 70:2075–85. 
68. Sorensen OE, Borregaard N. Neutrophil extracellular traps – the dark side of 
neutrophils. J Clin Invest (2016) 126:1612–20. doi:10.1172/JCI84538 
69. Gupta AK, Joshi MB, Philippova M, Erne P, Hasler P, Hahn S, et al. Activated 
endothelial cells induce neutrophil extracellular traps and are susceptible to 
NETosis-mediated cell death. FEBS Lett (2010) 584:3193–7. doi:10.1016/ 
j.febslet.2010.06.006 
70. Saffarzadeh M, Juenemann C, Queisser MA, Lochnit G, Barreto G, 
Galuska  SP, et  al. Neutrophil extracellular traps directly induce epithelial 
and endothelial cell death: a predominant role of histones. PLoS One (2012) 
7:e32366. doi:10.1371/journal.pone.0032366 
71. Huang H, Tohme S, Al-Khafaji AB, Tai S, Loughran P, Chen L, et  al. 
Damage-associated molecular pattern-activated neutrophil extracellular trap 
exacerbates sterile inflammatory liver injury. Hepatology (2015) 62:600–14. 
doi:10.1002/hep.27841 
72. Hoeksema M, Van Eijk M, Haagsman HP, Hartshorn KL. Histones as 
 mediators of host defense, inflammation and thrombosis. Future Microbiol 
(2016) 11:441–53. doi:10.2217/fmb.15.151 
73. Marcos V, Zhou Z, Yildirim AO, Bohla A, Hector A, Vitkov L, et al. CXCR2 
mediates NADPH oxidase-independent neutrophil extracellular trap for-
mation in cystic fibrosis airway inflammation. Nat Med (2010) 16:1018–23. 
doi:10.1038/nm.2209 
74. Leppkes M, Maueroder C, Hirth S, Nowecki S, Gunther C, Billmeier U, 
et al. Externalized decondensed neutrophil chromatin occludes pancreatic 
ducts and drives pancreatitis. Nat Commun (2016) 7:10973. doi:10.1038/
ncomms10973 
75. Wang H, Ward MF, Fan XG, Sama AE, Li W. Potential role of high mobility 
group box 1 in viral infectious diseases. Viral Immunol (2006) 19:3–9. 
doi:10.1089/vim.2006.19.3 
76. Cortjens B, De Boer OJ, De Jong R, Antonis AF, Sabogal Pineros YS, Lutter 
R, et  al. Neutrophil extracellular traps cause airway obstruction during 
respiratory syncytial virus disease. J Pathol (2016) 238:401–11. doi:10.1002/
path.4660 
7Schönrich and Raftery Virus-Induced NETosis
Frontiers in Immunology | www.frontiersin.org September 2016 | Volume 7 | Article 366
77. Hemmers S, Teijaro JR, Arandjelovic S, Mowen KA. PAD4-mediated 
neutrophil extracellular trap formation is not required for immunity 
against influenza infection. PLoS One (2011) 6:e22043. doi:10.1371/journal.
pone.0022043 
78. Ermert D, Urban CF, Laube B, Goosmann C, Zychlinsky A, Brinkmann V. 
Mouse neutrophil extracellular traps in microbial infections. J Innate Immun 
(2009) 1:181–93. doi:10.1159/000205281 
79. Saffarzadeh M, Preissner KT. Fighting against the dark side of neutrophil 
extracellular traps in disease: manoeuvres for host protection. Curr Opin 
Hematol (2013) 20:3–9. doi:10.1097/MOH.0b013e32835a0025 
80. Merkus PJ, De Hoog M, Van Gent R, De Jongste JC. DNase treatment for 
atelectasis in infants with severe respiratory syncytial virus bronchiolitis. Eur 
Respir J (2001) 18:734–7. 
81. Nasr SZ, Strouse PJ, Soskolne E, Maxvold NJ, Garver KA, Rubin BK, et al. 
Efficacy of recombinant human deoxyribonuclease I in the hospital man-
agement of respiratory syncytial virus bronchiolitis. Chest (2001) 120:203–8. 
doi:10.1378/chest.120.1.203 
82. Enriquez A, Chu IW, Mellis C, Lin WY. Nebulised deoxyribonuclease for 
viral bronchiolitis in children younger than 24 months. Cochrane Database 
Syst Rev (2012) 11:CD008395. doi:10.1002/14651858.CD008395.pub2 
83. Hahn S, Giaglis S, Hoesli I, Hasler P. Neutrophil NETs in reproduction: from 
infertility to preeclampsia and the possibility of fetal loss. Front Immunol 
(2012) 3:362. doi:10.3389/fimmu.2012.00362 
84. Grayson PC, Kaplan MJ. At the bench: neutrophil extracellular traps (NETs) 
highlight novel aspects of innate immune system involvement in autoimmune 
diseases. J Leukoc Biol (2016) 99:253–64. doi:10.1189/jlb.5BT0615-247R 
85. Hakkim A, Furnrohr BG, Amann K, Laube B, Abed UA, Brinkmann V, et al. 
Impairment of neutrophil extracellular trap degradation is associated with 
lupus nephritis. Proc Natl Acad Sci U S A (2010) 107:9813–8. doi:10.1073/
pnas.0909927107 
86. Leffler J, Martin M, Gullstrand B, Tyden H, Lood C, Truedsson L, et  al. 
Neutrophil extracellular traps that are not degraded in systemic lupus ery-
thematosus activate complement exacerbating the disease. J Immunol (2012) 
188:3522–31. doi:10.4049/jimmunol.1102404 
87. Sisirak V, Sally B, D’Agati V, Martinez-Ortiz W, Ozcakar ZB, David J, et al. 
Digestion of chromatin in apoptotic cell microparticles prevents autoimmu-
nity. Cell (2016) 166:88–101. doi:10.1016/j.cell.2016.05.034 
88. Hansen KE, Arnason J, Bridges AJ. Autoantibodies and common 
viral illnesses. Semin Arthritis Rheum (1998) 27:263–71. doi:10.1016/
S0049-0172(98)80047-4 
89. Ramos-Casals M. Viruses and lupus: the viral hypothesis. Lupus (2008) 
17:163–5. doi:10.1177/0961203307086268 
90. Ramos-Casals M, Cuadrado MJ, Alba P, Sanna G, Brito-Zeron P, 
Bertolaccini L, et al. Acute viral infections in patients with systemic lupus 
erythematosus: description of 23 cases and review of the literature. Medicine 
(Baltimore) (2008) 87:311–8. doi:10.1097/MD.0b013e31818ec711 
91. Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Shlomchik MJ, 
Marshak-Rothstein A. Chromatin-IgG complexes activate B cells by dual 
engagement of IgM and toll-like receptors. Nature (2002) 416:603–7. 
doi:10.1038/416603a 
92. Koma T, Yoshimatsu K, Nagata N, Sato Y, Shimizu K, Yasuda SP, et  al. 
Neutrophil depletion suppresses pulmonary vascular hyperpermeability and 
occurrence of pulmonary edema caused by hantavirus infection in C.B-17 
SCID mice. J Virol (2014) 88:7178–88. doi:10.1128/JVI.00254-14 
93. Kobak L, Raftery MJ, Voigt S, Kuhl AA, Kilic E, Kurth A, et al. Hantavirus-
induced pathogenesis in mice with a humanized immune system. J Gen Virol 
(2015) 96:1258–63. doi:10.1099/vir.0.000087 
94. Schonrich G, Kruger DH, Raftery MJ. Hantavirus-induced disruption of the 
endothelial barrier: neutrophils are on the payroll. Front Microbiol (2015) 
6:222. doi:10.3389/fmicb.2015.00222 
95. Kruger DH, Schonrich G, Klempa B. Human pathogenic hantaviruses 
and prevention of infection. Hum Vaccin (2011) 7:685–93. doi:10.4161/
hv.7.6.15197 
96. Lalwani P, Raftery MJ, Kobak L, Rang A, Giese T, Matthaei M, et  al. 
Hantaviral mechanisms driving HLA class I antigen presentation require 
both RIG-I and TRIF. Eur J Immunol (2013) 43:2566–76. doi:10.1002/eji. 
201243066 
97. Outinen TK, Kuparinen T, Jylhava J, Leppanen S, Mustonen J, Makela 
S, et  al. Plasma cell-free DNA levels are elevated in acute Puumala han-
tavirus infection. PLoS One (2012) 7:e31455. doi:10.1371/journal.pone. 
0031455 
98. Vaheri A, Strandin T, Jaaskelainen AJ, Vapalahti O, Jarva H, Lokki ML, et al. 
Pathophysiology of a severe case of Puumala hantavirus infection successfully 
treated with bradykinin receptor antagonist icatibant. Antiviral Res (2014) 
111:23–5. doi:10.1016/j.antiviral.2014.08.007 
99. Massberg S, Grahl L, Von Bruehl ML, Manukyan D, Pfeiler S, Goosmann 
C, et  al. Reciprocal coupling of coagulation and innate immunity via 
neutrophil serine proteases. Nat Med (2010) 16:887–96. doi:10.1038/ 
nm.2184 
100. Semeraro F, Ammollo CT, Morrissey JH, Dale GL, Friese P, Esmon 
NL, et  al. Extracellular histones promote thrombin generation through 
 platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4. 
Blood (2011) 118:1952–61. doi:10.1182/blood-2011-03-343061 
101. Gillrie MR, Lee K, Gowda DC, Davis SP, Monestier M, Cui L, et al. Plasmodium 
falciparum histones induce endothelial proinflammatory response and 
barrier dysfunction. Am J Pathol (2012) 180:1028–39. doi:10.1016/ 
j.ajpath.2011.11.037 
102. Simmons CP, Farrar JJ, Nguyen VV, Wills B. Dengue. N Engl J Med (2012) 
366:1423–32. doi:10.1056/NEJMra1110265 
103. Beatty PR, Puerta-Guardo H, Killingbeck SS, Glasner DR, Hopkins K, 
Harris E. Dengue virus NS1 triggers endothelial permeability and vascular 
leak that is prevented by NS1 vaccination. Sci Transl Med (2015) 7:304ra141. 
doi:10.1126/scitranslmed.aaa3787 
104. Modhiran N, Watterson D, Muller DA, Panetta AK, Sester DP, Liu L, et al. 
Dengue virus NS1 protein activates cells via toll-like receptor 4 and disrupts 
endothelial cell monolayer integrity. Sci Transl Med (2015) 7:304ra142. 
doi:10.1126/scitranslmed.aaa3863 
105. Jenne CN, Kubes P. Platelets in inflammation and infection. Platelets (2015) 
26:286–92. doi:10.3109/09537104.2015.1010441 
106. Juffrie M, Van Der Meer GM, Hack CE, Haasnoot K, Sutaryo, Veerman AJ, 
et al. Inflammatory mediators in dengue virus infection in children: interleu-
kin-8 and its relationship to neutrophil degranulation. Infect Immun (2000) 
68:702–7. doi:10.1128/IAI.68.2.702-707.2000 
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be 
construed as a potential conflict of interest.
Copyright © 2016 Schönrich and Raftery. This is an open-access article distributed 
under the terms of the Creative Commons Attribution License (CC BY). The use, 
distribution or reproduction in other forums is permitted, provided the original 
author(s) or licensor are credited and that the original publication in this journal 
is cited, in accordance with accepted academic practice. No use, distribution or 
reproduction is permitted which does not comply with these terms.
